(Q36206681)

12 August 2017

1 reference

title

Diagnosis and treatment of irritable bowel syndrome: state of the art. (English)

1 reference

12 August 2017

main subject

irritable bowel syndrome

1 reference

1

Kirsten Tillisch

1 reference

12 August 2017

Lin Chang

2

1 reference

12 August 2017

publication date

1 August 2005

1 reference

Current gastroenterology reports

12 August 2017

published in

1 reference

12 August 2017

volume

7

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

249-256

1 reference

https://scigraph.springernature.com/pub.10.1007/s11894-005-0016-y

12 August 2017

exact match

0 references

cites work

Cerebral activation in patients with irritable bowel syndrome and control subjects during rectosigmoid stimulation

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11894-005-0016-Y

A review of the evidence for overlap among unexplained clinical conditions

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11894-005-0016-Y

Diagnosing and treating patients with refractory functional gastrointestinal disorders

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11894-005-0016-Y

An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome

21 January 2018

1 reference

12 December 2020

Prognosis in post-infective irritable bowel syndrome: a six year follow up study.

1 reference

12 December 2020

The cost-effectiveness of psychotherapy and paroxetine for severe irritable bowel syndrome

1 reference

12 December 2020

Costs of care for irritable bowel syndrome patients in a health maintenance organization

1 reference

12 December 2020

Long-term safety of tegaserod in patients with constipation-predominant irritable bowel syndrome

1 reference

12 December 2020

Paroxetine to treat irritable bowel syndrome not responding to high-fiber diet: a double-blind, placebo-controlled trial

1 reference

12 December 2020

The impact of irritable bowel syndrome on health-related quality of life

1 reference

12 December 2020

Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial.

1 reference

12 December 2020

Acupuncture has a placebo effect on rectal perception but not on distensibility and spatial summation: a study in health and IBS

1 reference

12 December 2020

A double-blind, randomized, placebo-controlled dose-ranging study to evaluate the efficacy of alosetron in the treatment of irritable bowel syndrome

1 reference

12 December 2020

Systematic review on the management of irritable bowel syndrome in North America.

1 reference

12 December 2020

A randomized controlled clinical trial of the serotonin type 3 receptor antagonist alosetron in women with diarrhea-predominant irritable bowel syndrome

1 reference

12 December 2020

Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation

1 reference

12 December 2020

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

1 reference

12 December 2020

Regional brain activation in response to rectal distension in patients with irritable bowel syndrome and the effect of a history of abuse

1 reference

12 December 2020

Testing for celiac sprue in irritable bowel syndrome with predominant diarrhea: a cost-effectiveness analysis

1 reference

12 December 2020

Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study

1 reference

12 December 2020

Regional cerebral activity in normal and pathological perception of visceral pain.

1 reference

12 December 2020

Abnormal colonic endocrine cells in patients with chronic idiopathic slow-transit constipation

1 reference

12 December 2020

A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator

1 reference

12 December 2020

Systematic review: the economic impact of irritable bowel syndrome.

1 reference

12 December 2020

Functional bowel disorders and functional abdominal pain

1 reference

12 December 2020

Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.

1 reference

12 December 2020

Fibromyalgia in the irritable bowel syndrome: studies of prevalence and clinical implications

1 reference

12 December 2020

Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome

1 reference

12 December 2020

Increased platelet depleted plasma 5-hydroxytryptamine concentration following meal ingestion in symptomatic female subjects with diarrhoea predominant irritable bowel syndrome

1 reference

12 December 2020

Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications?

1 reference

12 December 2020

Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS.

1 reference

12 December 2020

Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial

1 reference

12 December 2020

Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome

1 reference

12 December 2020

Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel syndrome

1 reference

12 December 2020

Effect of tegaserod in chronic constipation: a randomized, double-blind, controlled trial

1 reference

12 December 2020

Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time

1 reference

12 December 2020

A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS.

1 reference

12 December 2020

Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders

1 reference

12 December 2020

Psychological treatments for irritable bowel syndrome: a systematic review and meta-analysis

1 reference

12 December 2020

Effects of loperamide oxide on gastrointestinal transit time and anorectal function in patients with chronic diarrhoea and faecal incontinence

1 reference

12 December 2020

Lower frequency of MMC is found in IBS subjects with abnormal lactulose breath test, suggesting bacterial overgrowth

1 reference

12 December 2020

Symptoms of psychologic distress associated with irritable bowel syndrome. Comparison of community and medical clinic samples

1 reference

12 December 2020

The mechanism of action of peppermint oil on gastrointestinal smooth muscle. An analysis using patch clamp electrophysiology and isolated tissue pharmacology in rabbit and guinea pig

1 reference

12 December 2020

Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome

1 reference

12 December 2020

Condition-specific deactivation of brain regions by 5-HT3 receptor antagonist Alosetron

1 reference

12 December 2020

Treatment of irritable bowel syndrome with Chinese herbal medicine: a randomized controlled trial.

1 reference

12 December 2020

Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome

1 reference

12 December 2020

Long term benefits of hypnotherapy for irritable bowel syndrome

1 reference

12 December 2020

Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study

1 reference

12 December 2020

Towards positive diagnosis of the irritable bowel

1 reference

12 December 2020

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist

1 reference

12 December 2020

Irritable bowel syndrome, health care use, and costs: a U.S. managed care perspective

1 reference

12 December 2020

Clinical determinants of health-related quality of life in patients with irritable bowel syndrome

1 reference

12 December 2020

American Gastroenterological Association medical position statement: irritable bowel syndrome

1 reference

12 December 2020

Ranking of symptoms by patients with the irritable bowel syndrome

1 reference

12 December 2020

Role of visceral sensitivity in the pathophysiology of irritable bowel syndrome

1 reference

12 December 2020

10.1007/S11894-005-0016-Y

Identifiers

DOI

1 reference

12 August 2017

1 reference